Sandra Zeckel

Consultant Advisor

Sandra Zeckel has 32 years of drug development experience at Eli Lilly and Co. with the last 17 years concentrated in project management. Sandra’s technical background includes Formulation Development, Regulatory, and Clinical Trial Materials Manufacturing. She has leveraged those experiences into cross-functional leadership roles as a project manager, leading teams towards successful product registrations. Sandra possesses drug development experience from pre-clinical to support of marketed products. She is also a certified a Six Sigma black belt, which Sandra utilizes to drive data based team decisions.

Core competencies include:

·         Firm understanding of Project Management methodology as defined by the Project Management Book of Knowledge (PMBOK)

·         Extensive knowledge of the drug development process from pre-clinical through marketed products

·         Leadership of cross-functional teams by driving commitment to the plan, issue resolution, team dynamics, communication, etc. to achieve stated objectives

·         Certified as a Six Sigma Black belt

·         CMC Regulatory experience in writing INDs and NDAs

·         Eight years experience working within the Oncology therapeutic area

·         Expertise in managing partner relationships through numerous partnered projects

·      Proficient in the use of Microsoft Project, PowerPoint, Excel and Word